Take IV Iron Therapy to a proven place: Response with toleration!

Venofer® (iron sucrose injection, USP) provides first-line IV iron therapy for pre-dialysis chronic kidney disease patients in treatment of iron deficiency anemia. It is effective with or without erythropoietin.

American Regent. Enriching the lives of anemia patients. ™

IMPORTANT SAFETY INFORMATION: Venofer® (iron sucrose injection, USP) is contraindicated in patients with evidence of iron overload, in patients with known hypersensitivity to Venofer® or any of its inactive components, and in patients with anemia not caused by iron deficiency. Hypersensitivity reactions have been reported with IV iron products. Hypotension has been reported frequently in hemodialysis dependent-chronic kidney disease (HDD-CKD) patients receiving IV iron, and has also been reported in non-dialysis dependent (NDD) and peritoneal dialysis dependent (PDD)-CKD patients receiving IV iron. Hypotension following administration of Venofer® may be related to rate of administration and total dose delivered.

In multi-dose efficacy studies in HDD-CKD patients (N=231), the most frequent adverse events (>5%), whether or not related to Venofer® administration, were hypotension, muscle cramps, nausea, headache, graft complications, vomiting, dizziness, hypertension, chest pain, and diarrhea. In post-marketing safety studies in HDD-CKD patients (N=1051), the most frequent adverse events reported (>1%), whether or not related to Venofer® administration, were congestive heart failure, sepsis, and taste disturbance. In multi-dose efficacy studies in NDD-CKD patients (N=91), the most frequent adverse events (≥5%), whether or not related to Venofer® administration, were taste disturbance, peripheral edema, diarrhea, constipation, nausea, dizziness, and hypertension. In the study of PDD-CKD patients (N=75), the most frequent adverse events, whether or not related to Venofer®, reported by ≥5% of these patients were diarrhea, peritoneal infection, vomiting, hypertension, pharyngitis, peripheral edema, and nausea.


Please see Full Prescribing Information.